UBS O'Connor’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,861	Closed	-$1.16M	–	415
2025 Q2	$1.16M	Sell	31,861 -55,950	-64%	-$2.02M	0.03%	196
2025 Q1	$3.18M	Buy	87,811 +65,527	+294%	+$2.73M	0.08%	88
2024 Q4	$937K	Buy	22,284 +1,015	+5%	+$50.4K	0.02%	234
2024 Q3	$1.18M	Sell	21,269 -13,859	-39%	-$706K	0.03%	258
2024 Q2	$1.44M	Sell	35,128 -7,478	-18%	-$319K	0.04%	242
2024 Q1	$1.99M	Sell	42,606 -14,350	-25%	-$677K	0.06%	173
2023 Q4	$2.72M	Sell	56,956 -19,959	-26%	-$774K	0.09%	133
2023 Q3	$2.74M	Buy	76,915 +9,567	+14%	+$379K	0.05%	188
2023 Q2	$3.11M	Buy	67,348 +8,072	+14%	+$374K	0.07%	187
2023 Q1	$2.38M	Buy	+59,276	New	+$2.54M	0.06%	281
2015 Q2	–	Sell	-20,000	Closed	-$1.24M	–	869
2015 Q1	$1.24M	Sell	20,000 -5,000	-20%	-$278K	0.03%	365
2014 Q4	$1.1M	Buy	+25,000	New	+$1.15M	0.02%	349